News Releases

This information is part of the archives and is no longer current and may no longer be accurate.

Keyword Search
 
2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010
DateTitle 
Oct 31, 2016DURECT Corporation Announces Third Quarter 2016 Financial Results and Update of ProgramsPrinter Friendly Version
Oct 31, 2016DURECT Corporation Announces Update on DUR-928 Development ProgramPrinter Friendly Version
Oct 21, 2016DURECT Corporation Invites You to Join its Third Quarter 2016 Earnings Conference CallPrinter Friendly Version
Sep 26, 2016DURECT's Licensee Pain Therapeutics Receives Complete Response Letter from FDA for REMOXY® ER (oxycodone) Extended-Release Capsules CIIPrinter Friendly Version
Sep 06, 2016DURECT to Present at the Rodman & Renshaw Global Investment ConferencePrinter Friendly Version
Aug 01, 2016DURECT Corporation Announces Second Quarter 2016 Financial Results and Update of ProgramsPrinter Friendly Version
Jul 25, 2016DURECT Corporation Invites You to Join its Second Quarter 2016 Earnings Conference CallPrinter Friendly Version
Jul 01, 2016DURECT Provides REMOXY® UpdatePrinter Friendly Version
Jun 28, 2016DURECT to Present at the Cantor Fitzgerald Healthcare ConferencePrinter Friendly Version
May 31, 2016DURECT to Present at the Jefferies Healthcare ConferencePrinter Friendly Version
May 19, 2016DURECT Announces FDA Advisory Committee Meeting for REMOXY®Printer Friendly Version
May 11, 2016DURECT Announces New REMOXY® Data being Presented at American Pain Society MeetingPrinter Friendly Version
May 05, 2016DURECT Corporation Announces First Quarter 2016 Financial Results and Update of ProgramsPrinter Friendly Version
Apr 29, 2016DURECT Announces Closing of Public Offering of Common StockPrinter Friendly Version
Apr 28, 2016DURECT Corporation Invites You to Join its First Quarter 2016 Earnings Conference CallPrinter Friendly Version
Apr 26, 2016DURECT Announces Pricing of Public Offering of Common StockPrinter Friendly Version
Apr 25, 2016DURECT Announces Proposed Public Offering of Common StockPrinter Friendly Version
Apr 12, 2016DURECT Announces FDA Acceptance of REMOXY® NDA, PDUFA Date of September 25, 2016Printer Friendly Version
Apr 07, 2016DURECT Announces POSIMIR® Program UpdatePrinter Friendly Version
Mar 29, 2016DURECT Announces Resubmission of REMOXY® New Drug Application to the U.S. Food and Drug AdministrationPrinter Friendly Version
Feb 29, 2016DURECT Corporation Announces Fourth Quarter 2015 Financial Results and Update of ProgramsPrinter Friendly Version
Feb 18, 2016DURECT Corporation Invites You to Join its Fourth Quarter 2015 Earnings Conference CallPrinter Friendly Version
Jan 28, 2016DURECT to Present at the BIO CEO & Investor ConferencePrinter Friendly Version
Jan 11, 2016DURECT Announces Initiation of DUR-928 Dosing in PatientsPrinter Friendly Version
Jan 06, 2016DURECT Announces Positive Phase 1 Data for DUR-928Printer Friendly Version